The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AEVA TECHNOLOGIES INC COM 00835Q103   21,997,384 18,485,197 SH   SOLE   18,485,197 0 0
DAY ONE BIOPHARMACEUTICALS I COM 23954D109   34,072,148 2,548,403 SH   SOLE   2,548,403 0 0
RALLYBIO CORP COM 75120L100   11,760,956 2,059,712 SH   SOLE   2,059,712 0 0
TYRA BIOSCIENCES INC COM 90240B106   70,868,555 4,409,991 SH   SOLE   4,409,991 0 0
VECTIVBIO HLDG AG ORD SHS H9060V101   315,304 37,051 SH   SOLE   37,051 0 0